Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index; 9 of the 16 sources its claims cite were checked for support.
Abstract
INTRODUCTION: Medication adherence continues to be a significant challenge in healthcare, and there is a shortage of effective interventions in this area. This scoping review studied the patient-related factors of medication adherence. METHODS: We searched Medline Ovid, Scopus, and Cochrane Library from January 2009 to June 2021 to find the most recent original qualitative studies or systematic reviews that addressed the patient-related factors of medication adherence in treating chronic conditions. We used the PRISMA-ScR checklist to ensure the quality of the study. RESULTS: The initial search revealed 4404 studies, of which we included 89 qualitative studies in the scoping review. We inductively organized the patient-related factors causing barriers, as well as the facilitators to medication adherence. The studies more often dealt with barriers than facilitators. We classified the factors as patient-specific, illness-specific, medication-related, healthcare and system-related, sociocultural, as well as logistical and financial factors. Information and knowledge of diseases and their treatment, communication, trust in patient-provider relationships, support, and adequate resources appeared to be the critical facilitators in medication adherence from the patient perspective. DISCUSSION AND CONCLUSIONS: Patients are willing to discuss their concerns about medications. Better communication and better information on medicines appear to be among the critical factors for patients. The findings of this scoping review may help those who plan further interventions to improve medication adherence.
Overview
CoChat Summary
## TL;DR
This scoping review synthesized qualitative evidence on why patients with chronic conditions do or do not adhere to medication, including 89 original peer-reviewed studies and 13 prior systematic reviews. It found that barriers were reported more often than facilitators, and that information, communication, trust, support, and practical resources were central to adherence.
## Key findings
- The review included 89 original peer-reviewed qualitative articles and 13 systematic reviews; the original studies came from 36 countries.
- The evidence was organized into six barrier domains: patient-specific, illness-specific, medication-related, healthcare/system-related, sociocultural, and logistical/financial factors.
- The evidence was organized into five facilitator domains: information/knowledge, individual and social motivation, behavioural skills, healthcare/system factors, and logistical/financial factors.
- The authors report that studies more often dealt with barriers than facilitators; they also note 17 studies used a behaviour-theory-based approach.
## Methods
- Design: Scoping review of qualitative research, reported using PRISMA-ScR.
- Data/sample: Searches of MEDLINE (Ovid), Scopus, and the Cochrane Library were run on 23 September 2019 and updated on 9 June 2021; included studies were published from January 2009 to June 2021, in English, and in peer-reviewed journals.
- Analysis: Titles/abstracts and full texts were screened by multiple reviewers in Covidence; the team did not assess risk of bias; data were extracted independently by two reviewers and then inductively categorized into barrier/facilitator themes, with the IMB model used as part of the facilitator classification.
## Limitations
- The paper states that, because it focused on qualitative aspects, it cannot conclude the magnitude of the effect of the factors influencing adherence.
- The search was limited to English-language studies, which the authors say may be a source of bias.
- The authors note that the review found more barriers than facilitators, which they call a limitation, though they also interpret this as reflecting the literature’s greater focus on barriers.
- Evident from the text: the review excluded studies before 2009, so older qualitative evidence is not covered.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
7 Valid · 1 Not valid · 3 Not checked · 39 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The same factors that improve medication adherence may also decrease it [9,10,11].”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [9] Bauler S. Jacquin-Courtois S. Haesebaert J. Luaute J. Coudeyre E. Feutrier C. Allenet B. Decullier E. Rode G. Janoly-Dumenil A. Barriers and facilitators for medication adherence in stroke patients: A qualitative study conducted in french neurological rehabilitation units Eur. Neurol. 2014 72 262 270 10.1159/000362718 25277833 source
- Supportedcites [10] Nielsen T.M. Juhl M.F. Feldt-Rasmussen B. Thomsen T. Adherence to medication in patients with chronic kidney disease: A systematic review of qualitative research Clin. Kidney J. 2018 11 513 527 10.1093/ckj/sfx140 30094015 PMC6070096 source
The Discussion (page not supplied) says that dosette boxes and memory tools may affect adherence both positively and negatively. It explains that these tools can help forgetful patients but may be barriers for patients with impaired vision, sensory disturbances or reading difficulties. (LLM, conf=0.92)
- Supportedcites [11] Rezaei M. Valiee S. Tahan M. Ebtekar F. Gheshlagh R.G. Barriers of medication adherence in patients with type-2 diabetes: A pilot qualitative study Diabetes Metab. Syndr. Obes. Targets Ther. 2019 12 589 599 10.2147/DMSO.S197159 PMC6507070 31118722 source
The Discussion (page unavailable) says family trust and support can improve adherence. The Results, under “Interactive/economic challenges” (page unavailable), describe how an unsupportive partner can discourage regular medication use. Together, these passages support the claim that family-related factors can affect adherence in either direction. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We identified similar factors to medication adherence in the previous systematic qualitative reviews (n = 13, Table A2) as in the qualitative studies described above (n = 76, Table A1).”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > 3. Results > 3.3. Summary of Findings
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The studies more often dealt with barriers than facilitators.”
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
“Overall, the studies reported more barriers than facilitators to medication adherence.”
- Also stated in: § 3.3. Summary of Findings · plain
“the studies were more often concerned with barriers than facilitators.”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > Abstract
plainn = 89- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We classified the factors as patient-specific, illness-specific, medication-related, healthcare and system-related, sociocultural, as well as logistical and financial factors.”
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
“We inductively identified six subject areas with subcategories related to barriers to medication adherence based on the included qualitative studies (n = 89).”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > Abstract
plainn = 89- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Barriers to Medication Adherence · plain
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, external circumstances affect adherence, such as financial problems or poor access to care, which have to be considered.”
§ Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research > 4. Discussion > 4.1. Main Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
13 more claims
Create a free account to see all 50 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 21
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Restrictive conditions for the intake of oral medications may adversely affect treatment adherence and compliance and, consequently, patient outcomes [23,24].”
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Human error: models and management
Reason, J. (2000) · BMJ · doi:10.1136/bmj.320.7237.768 · Cited by 5,665
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945 · cited 2×
“have combined the existing evidence of adherence interventions [3].”
BackgroundFisher, J. D., & Fisher, W. A. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.3.455 · Cited by 2,459
Updated methodological guidance for the conduct of scoping reviews
Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2021) · JBI Evidence Implementation · doi:10.1097/xeb.0000000000000277 · Cited by 1,461
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Rasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Adherence and health care costs
McGuire, M., & Iuga (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 708
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · PubMed · Cited by 625
Cited by
Medication nonadherence: health impact, prevalence, correlates and interventions
Stewart, S.-J., Moon, Z., & Horne, R. (2022) · Psychology and Health · doi:10.1080/08870446.2022.2144923 · Cited by 228
“Further, research suggests that better patient–clinician communication (e.g. support and trust in a patient-clinician relationship) facilitates adherent behaviour (Beckmann et al., 2021; Jackson et al., 2010; Kvarnström et al., 2021; Matthias et al., 2012; Wilson et al., 2010).”
BackgroundChauke, G. D., Nakwafila, O., Chibi, B., Sartorius, B. K. D., & Mashamba-Thompson, T. P. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09716 · Cited by 160
Yoon, S., Kwan, Y. H., Yap, W. L., Lim, Z. Y., Phang, J. K., Loo, Y. X., Aw, J., & Low, L. L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1124297 · Cited by 63
“When comparing our results on healthcare team and systemrelated dimension to recent reviews which assessed factors associated with medication non-adherence (Konstantinou et al., 2020; Kvarnström et al., 2021), we found that language issue was more prominent in our healthcare settings.”
BackgroundResultIqbal, A., Richardson, C. L., Iqbal, Z., O’Keefe, H., Hanratty, B., Matthews, F. E., & Todd, A. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03835-z · Cited by 52
González-Bueno, J., Sevilla‐Sánchez, D., Juvanteny, E. P., Molist‐Brunet, N., Codina‐Jané, C., & Espaulella‐Panicot, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189606 · Cited by 59
“, pointing out communication and information on medicines among the critical factors for medication adherence [45].”
BackgroundKardas, P., Bennett, B. L., Borah, B. J., Burnier, M., Daly, C., Hiligsmann, M., Menditto, E., Peterson, A. M., Slejko, J. F., Tóth, K., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1444012 · Cited by 64
Mgwenya, T. N., Abrahamse, H., & Houreld, N. N. (2024) · Wound Repair and Regeneration · doi:10.1111/wrr.13239 · Cited by 48
Fibromyalgia: Understanding, Diagnosis and Modern Approaches to Treatment
Filipovic, T., Filipović, A., Nikolic, D., Gimigliano, F., Stevanov, J., Hrkovic, M., & Bosanac, I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030955 · Cited by 47
Ma, X., Liu, R., Pratt, E. J., Benson, C. T., Bhattachar, S. N., & Sloop, K. W. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01554-1 · Cited by 38
“Restrictive conditions for the intake of oral medications may adversely affect treatment adherence and compliance and, consequently, patient outcomes [23, 24].”
BackgroundAntalfy, A., Berman, K., Everitt, C., Alten, R., Latymer, M., & Godfrey, C. M. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02671-2 · Cited by 38
“For example, older patients seemmore likely than younger patients to have high adherence [38–40], and more ownership of self-managing medications may also improve adherence [41].”
BackgroundChen, Y., Gao, J., & Lu, M. (2023) · Journal of Advanced Nursing · doi:10.1111/jan.15776 · Cited by 59
Schuuring, M. J., Treskes, R. W., Castiello, T., Jensen, M. T., Casado-Arroyo, R., Neubeck, L., Lyon, A. R., Keser, N., Rucinski, M., Marketou, M. E., et al. (2024) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztae064 · Cited by 43
Barriers and Facilitators to Medication Adherence among the Vulnerable Elderly: A Focus Group Study
Horvat, M., Eržen, I., & Vrbnjak, D. (2024) · Healthcare · doi:10.3390/healthcare12171723 · Cited by 47
“Poor patient–provider relationships lead to insufficient patient counselling and leave the patient alone struggling with medication problems [57].”
BackgroundEmamikia, S., Gentline, C., Enman, Y., & Parodis, I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071857 · Cited by 39
“Overall, our findings concurred with suggestions for interventions against medication non-adherence derived from previous studies involving patients with SLE [2,41,42] and other chronic diseases [43].”
ResultMaggio, M. G., Bonanno, M., Manuli, A., & Calabrò, R. S. (2024) · Brain Sciences · doi:10.3390/brainsci14020140 · Cited by 41
Shahrestanaki, E., Khonsari, N. M., Seif, E., Baygi, F., Ejtahed, H., Sheidaei, A., Djalalinia, S., Magliano, D. J., & Qorbani, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1305304 · Cited by 42
Medication Adherence in Cancer Patients: A Comprehensive Review
Reshma, V., Chacko, A. M., Abdulla, N. H., Annamalai, M., & Kandi, V. (2024) · Cureus · doi:10.7759/cureus.52721 · Cited by 69
“It might be necessary to disclose the sickness, which the patient might find terrifying [45].”
BackgroundWhen blood pressure refuses to budge: exploring the complexity of resistant hypertension
Champaneria, M. K., Patel, R., & Oroszi, T. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1211199 · Cited by 32
Tackling polypharmacy in geriatric patients: Is increasing physicians’ awareness adequate?
Sutanto, H. (2025) · Archives of Gerontology and Geriatrics Plus · doi:10.1016/j.aggp.2025.100185 · Cited by 39
Hafez, G., Aarnio, E., Mucherino, S., Kamusheva, M., Qvarnström, M., Potočnjak, I., Trečiokienė, I., Mihajlović, J., Ekenberg, M., van Boven, J. F. M., et al. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08851-2 · Cited by 28
Fallatah, M. S., Alghamdi, G. S., Alzahrani, A. A., Sadagah, M. M., & Alkharji, T. M. (2023) · Cureus · doi:10.7759/cureus.37592 · Cited by 32
“In addition to patient-related factors, healthcare providers should also focus on healthcare system-related factors that affect medication adherence [15-18].”
BackgroundQadus, S., Naser, A. Y., Ofori‐Asenso, R., Ademi, Z., Awawdeh, S. A., & Liew, D. (2022) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-022-00553-6 · Cited by 31
“Measures to minimise the impact of disease management, such as financial burden on patients, could also help reduce non-adherence [46].”
BackgroundKalantzi, V., Kalafati, I. P., Belitsi, V., Tsiampalis, T., Koutsonasios, I., Androutsos, O., Bonoti, F., Panagiotakos, D. B., & Kosti, R. I. (2023) · Life · doi:10.3390/life13051153 · Cited by 30
“The above mentioned factors have already been well-reported in a recently published review exclusively evaluating medication adherence from the patient’s perspective in chronic diseases [51].”
BackgroundLanke, V., Trimm, K., Habib, B., & Tamblyn, R. M. (2025) · Journal of Medical Internet Research · doi:10.2196/60822 · Cited by 44
“The causes of medication nonadherence are complex and can include insufficient information about the illness and the use of medications, adverse medication effects, inability to pay for medication, and poor memory [5,8].”
Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
Jiao, Y., Liu, Y., & Jin, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-81903-z · Cited by 24
“Although less severe compared to anaphylactic shock or hypotension, skin rashes can still affect patient comfort and treatment adherence 32,33 .”
Kwakye, A. O., Kretchy, I. A., Peprah, P., & Mensah, K. B. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100426 · Cited by 31
A Comprehensive Review on Managing Fracture Calcaneum by Surgical and Non-surgical Modalities
Chirayath, A., Dhaniwala, N. S., & Kawde, K. (2024) · Cureus · doi:10.7759/cureus.54786 · Cited by 28
“Addressing patients' concerns or questions about their medications fosters a collaborative approach to pain management, contributing to overall well-being during recovery [59].”
BackgroundGao, Y.-Q., Yan, K., Yan, X., Xi, N., Gao, J., & Ren, H. (2022) · Nursing Open · doi:10.1002/nop2.1566 · Cited by 23
“Because HL is a potential factor influencing patients' health- related behaviours such as medication adherence, treatment beliefs and self- management skills (Kvarnström et al., 2021; Suhail et al., 2021).”
BackgroundAminde, L. N., Agbor, V. N., Fongwen, N. T., Ngwasiri, C. A., Nkoké, C., Nji, M., Dzudié, A., & Schutte, A. E. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037555 · Cited by 38
“103,106,107 These benefits include increased satisfaction, quality of life, and improved understanding of hypertension.”
Bellass, S., Scharf, T., Errington, L., Davies, K. A. B., Robinson, S. M., Runacres, A., Ventre, J. P., Witham, M. D., Sayer, A. A., & Cooper, R. (2024) · BMC Medicine · doi:10.1186/s12916-023-03220-y · Cited by 19
Fond, G. B., Falissard, B., Nuss, P., Collin, C., Duret, S., Rabbani, M., Chefdebien, I. D., Tonelli, I., Llorca, P., & Boyer, L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02154-4 · Cited by 20
“Medication observance/compliance is a major issue in all chronic illnesses [8, 9] but is particularly problematic in schizophrenia for various reasons, including poor patient insight into their illness, mental stigma, treatment refusal, lack of effectiveness and adverse events with APs [10, 11].”
BackgroundBonsu, K. O., Young, S. W., Lee, T. A., Nguyen, H. V., & Chitsike, R. S. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s367105 · Cited by 17
“Care fragmentation and lack of coordination lead to discontinuation of care and ultimately affect medication adherence.(19) Multidisciplinary care models draw on the expertise of various healthcare professionals in a specialized discipline and have the potential to improve clinical outcomes through provision of improv…”
BackgroundStudying the Impact of Clinical Decision-Making and Critical Thinking on the Quality of Nursing Care
İlaslan, E., Adıbelli, D., Teskereci, G., & Cura, Ş. Ü. (2023) · Journal of integrative nursing and palliative care · doi:10.51847/fstlidady3 · Cited by 18
“Thus, the quality of health care largely depends on the way nurses do services [1-4].”
Medication adherence: measurement methods and approaches
Schnorrerova, P., Matalová, P., & Wawruch, M. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_40 · Cited by 32
Singh, P. K. M., Krishnan, E. K., Lazim, N. M., Yaacob, N. M., & Abdullah, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112459 · Cited by 21
“Patientrelated factors include unintentional factors for example forgetting to take medication or inadequate understanding of dose or schedules, and intentional factors involve an active decision to stop or modify a treatment regimen based on ability to pay, beliefs and attitudes about their disease, medication side e…”
BackgroundPatients’ Characterization of Medication, Emotions, and Incongruent Perceptions around Adherence
Tu, P., Smith, D., Clark, R. E., Bayzle, L., Tu, R., & Lin, C. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100975 · Cited by 15
“At the same time, patients’ willingness to accept regimens also relies on their perceptions toward medication and persistent behavior to complete the therapy process [16,19,35].”
BackgroundLu, S., Leung, B. M. Y., Bruton, A. M., Millington, E., alexander, E., Camden, K., Hatsu, I. E., Johnstone, J. M., & Arnold, L. E. (2022) · Child Care Health and Development · doi:10.1111/cch.12995 · Cited by 30
Zewdu, W. S., Dagnew, S. B., Tarekegn, G. Y., Yazie, T. S., Ayicheh, M. A., Dagnew, F. N., & Moges, T. A. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06838-9 · Cited by 23
Koshatwar, M., Acharya, S., Prasad, R., Lohakare, T., Wanjari, M. B., & Taksande, A. B. (2023) · Cureus · doi:10.7759/cureus.44763 · Cited by 20
“Factors such as age, comorbidities, medication adherence, and patient goals should be considered to develop personalized treatment plans [90].”
Oliveira, C., JOSÉ, H. M. G., & Costa, E. (2024) · Nursing Reports · doi:10.3390/nursrep14030129 · Cited by 29
Craig, H. C., Alsaeed, D., Heneghan, H., Al-Najim, W., Al Ozairi, E., & le Roux, C. W. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01524-4 · Cited by 15
“Medication compliance means that the patient complies with the physician ’ s authority, while medication adherence refers to a collaboration between physician and patient in an effort to improve patient health [7].”
Kamangu, J. W. N., & Mboweni, S. H. (2024) · The Open Public Health Journal · doi:10.2174/0118749445299654240402033559 · Cited by 18
Thu, N. Q., Tien, N. T. N., Yen, N. T. H., Duong, T., Long, N. P., & Nguyen, H. T. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.09.009 · Cited by 20
(2023) · doi:10.1080/17474086.2023.2178409 · Cited by 15
“Some common factors that are seen to affect adherence to therapy included burden of pills, duration of medication administration, and route of medication administration [82].”
BackgroundFenta, E. T., Ayal, B. G., Kidie, A. A., Anagaw, T. F., Mekonnen, T., Bogale, E. K., Berihun, S., Tsega, T. D., Munie, C. M., Fenta, T. T., et al. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s452196 · Cited by 25
“76 Medication adherence among patients with non-communicable diseases was hampered by the high cost of medications and the scarcity of NCD medications in public facilities.”
BackgroundWhy Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors
Tran, N., Kouyate, A., & Hahn, M. (2022) · The AMA Journal of Ethic · doi:10.1001/amajethics.2022.181 · Cited by 19
Long acting injectables for the treatment of prostate cancer
Modi, D., Hussain, M. S., Ainampudi, S., & Prajapati, B. G. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105996 · Cited by 23
Vaismoradi, M., Mardani, A., Lillo‐Crespo, M., Logan, P., & Sak‐Dankosky, N. (2024) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241289205 · Cited by 18
“56 In ,70–72 From the clinical perspective, discontinuation can pose significant challenges for patients due to physiological and psychological dependence on medications during the treatment process.”
BackgroundMedication Non-adherence in Older Adults: Underlying Factors, Potential Interventions and Outcomes
Raj, E. A., Vilakkathala, R., & George, J. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01249-7 · Cited by 20
“Unwanted and unused medications often result from inadequate communication between health professionals and patients about health problems and how they might be treated, and about patients’ ongoing assessment and experience of treatments [13].”
Lutfian, L., Wardika, I. J., Mukminin, M. A., Zamroni, A. H., Rizanti, A. P., Chandra, I. N., Widyaningtyas, R., Maressa, A., & Maulana, S. (2025) · Tropical Medicine & International Health · doi:10.1111/tmi.14133 · Cited by 28
“A significant barrier to adherence is limited patient knowledge about the disease and its treatment [13, 14].”
Adherence to the antirheumatic drugs: a systematic review and meta-analysis
Aksoy, N., Ozturk, N., Ágh, T., & Kardas, P. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1456251 · Cited by 24
Kaplan, A. J., Ladin, K., Junna, S., Lindenberger, E. C., & Ufere, N. N. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.04.003 · Cited by 12
“16 Prior studies have highlighted deficits in illness understanding among patients with cirrhosis.”
A narrative review on the psychosocial domains of the impact of organ transplantation
Aderinto, N., Olatunji, G. D., Kokori, E., Ogieuhi, I. J., Moradeyo, A. A., Woldehana, N. A., Lawal, Z. D., Adetunji, B., Assi, G., Nazar, M. W., et al. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00148-y · Cited by 22
“Studies have demonstrated a strong association between pre-transplant psychosocial vulnerability markers and both medical and psychosocial adverse outcomes [106].”
Financial burden of heart failure in Malaysia: A perspective from the public healthcare system
Ong, S. C., & Low, J. Z. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288035 · Cited by 14
Fadil, H. A., Sammman, W. A., & Elshafie, R. M. (2023) · International Journal of Clinical Practice · doi:10.1155/2023/3312310 · Cited by 18
The Role of Artificial Intelligence in Shaping the Doctor–Patient Relationship: A Narrative Review
Merlo, E. M., Sparacino, G., Silvestro, O., Giacobello, M. L., Meduri, A., Casciaro, M., Gangemi, S., & Martino, G. (2026) · Healthcare · doi:10.3390/healthcare14040481 · Cited by 18
Twekambe, E., Epuitai, J., Kagoya, E. K., Namanya, V., Ayikobua, E. T., Obakiro, S. B., Napyo, A. K., & Kiyimba, K. (2023) · medRxiv · doi:10.1101/2023.02.04.23285423 · Cited by 12
Majellano, E. C., Clark, V. L., McLoughlin, R. F., Gibson, P. G., & McDonald, V. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269038 · Cited by 10
“In a scoping review on barriers and facilitators to medication adherence, patient desired for more open communication and better information [34].”
BackgroundResultPolysaccharide-based hydrogels for atopic dermatitis management: A review
Rao, H., & Tan, J. B. L. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122966 · Cited by 17
Kiiski, A., Luoma, E., Airaksinen, M. S. A., Pohjanoksa-Mäntylä, M., Desselle, S. P., & Kivelä, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093122 · Cited by 19
Self-citationMansoor, H., Manion, D., Kucharska‐Newton, A., Delcher, C., Lo‐Ciganic, W., Jicha, G. A., & Moga, D. C. (2024) · Stroke · doi:10.1161/strokeaha.124.048058 · Cited by 12
Improving adherence to medication in an intelligent environment using reinforcement learning
Ismail, A., Naeem, M., Khalid, U. B., & Abbas, M. (2024) · Journal of Reliable Intelligent Environments · doi:10.1007/s40860-024-00242-y · Cited by 13
How do others cope? Extracting coping strategies for adverse drug events from social media
Dirkson, A. R., Verberne, S., van Oortmerssen, G., Gelderblom, H. A. J., & Kraaij, W. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104228 · Cited by 14
Aby, E. S., Shen, T., Murugappan, M. N., Stenehjem, D. D., & Leventhal, T. M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000215 · Cited by 13
“A multitude of factors contribute to low rates of treatment retention, including but not limited to drug cost, side effects, difficulty with dosing schedule, patients’ lack of understanding of their disease and associated treatment, patients’ beliefs about the benefits of prescribed regimens, and forgetfulness.[22] Pr…”
BackgroundEvaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study
Boie, S. D., Glastetter, E., Lux, M. P., Balzer, F., Kalle, C. V., Lenz, C., & Müller, U. (2025) · JMIR Cancer · doi:10.2196/68426 · Cited by 17
Mamaghani, E. A., Soleimani, A., & Zirak, M. (2024) · International Journal of Nursing Studies Advances · doi:10.1016/j.ijnsa.2024.100278 · Cited by 14
A scoping review of interventions to optimize medication adherence in hypertension comorbidity
Kwakye, A. O., Hutton-Nyameaye, A., Cobbold, C. C., Boachie‐Ansah, P., & Kretchy, I. A. (2025) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2025.01.008 · Cited by 16
Odhiambo, C. O., Ablonczy, L., Wright, P. J., Corbett, C. F., Reichardt, S., & Valafar, H. (2023) · JMIR Human Factors · doi:10.2196/42714 · Cited by 12
“In this study, we focused on the global public health challenge of medication adherence, as only approximately 50% of people adhere to their medication regimens [1].”
Quality of medicines and public health in Latin America and the Caribbean (LAC): a review
Husaini, D. C., Bolon, F., Smith, N., Reynolds, R., Humes, S., & Cayetano, V. (2023) · International Journal of Pharmaceutical and Healthcare Marketing · doi:10.1108/ijphm-07-2022-0061 · Cited by 11
Owusu, R., Bawua, S. A., Kwarteng, E. B., Baatiema, L., & Nonvignon, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311994 · Cited by 9
Sacre, H., Haddad, C., Sakr, F., Safwan, J., Hajj, A., Zeenny, R. M., Akel, M., & Salameh, P. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2371409 · Cited by 11
“For instance, monthly income and financial well-being are often associated with unequal access to healthcare resources, potentially hindering patients from obtaining and adhering to prescribed medications (Kvarnström et al., 2021).”
BackgroundBelitsi, V., Tsiampalis, T., Kouvari, M., Kalantzi, V., Androutsos, O., Bonoti, F., Panagiotakos, D. B., & Kosti, R. I. (2023) · Life · doi:10.3390/life13091880 · Cited by 12
“As a consequence, patients may resort to avoidance behaviors, including skipping doses or discontinuing medications altogether, as mechanisms to cope with their anxieties surrounding their health and prescribed medications [66].”
Mikkola, H., Dimitrow, M. S., Hämeen‐Anttila, K., Laukkanen, E., & Airaksinen, M. S. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-077214 · Cited by 10
Self-citationNakwafila, O., Sartorius, B. K. D., Shumba, T. W., Dzinamarira, T., & Mashamba-Thompson, T. P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068238 · Cited by 10
Nascimento, T., Andrade, A., Pinto, E. A. M., Cabrita, C., Pais, S., & la Puerta, R. D. (2025) · Diabetology · doi:10.3390/diabetology6050033 · Cited by 23
“Non-adherence to therapy is not merely a patient-related issue but rather a multifaceted problem influenced by socioeconomic, medical, psychological, and pharmacotherapeutic factors [33–35].”
Wang, T., Li, Z., Wei, Y., Zhang, X., Yuan, Q., Zhang, X., Li, X., & Lei, Q. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07350-w · Cited by 14
“Various factors contribute to medication non-adherence that can be divided into multiples groups [31, 38].”
Alofi, R. M., Alrohaily, L. S., Jan, R. A., Alsaedi, S. L., Mahrous, F. A., & Alreefi, M. M. (2023) · Cureus · doi:10.7759/cureus.40686 · Cited by 15
“Other factors that may affect medication adherence are support from family, good communication between the patient and the doctor, and the financial situation [6].”
BackgroundPlaitano, E. G., McNeish, D., Bartels, S. M., Bell, K. R., Dallery, J., Grabinski, M. J., Kiernan, M., Lavoie, H. A., Lemley, S. M., Lowe, M. R., et al. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1467772 · Cited by 10
(2023) · doi:10.1055/s-0043-1775995 · Cited by 8
“6 Such insights into the identi fi cation of the most meaningful symptoms and primary outcome measures have the potential to enhance the model validity of clinical trials, as highlighted by Mathie et al. 7 This patient-centered approach also ensures that the chosen therapeutic targets align closely…”
A Practical Guide on Behaviour Change Support for Self-Managing Chronic Disease
Guerreiro, M. P., Félix, I. B., & Marques, M. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-20010-6 · Cited by 12
Bhattacharya, D., Brown, T. J., Clark, A., Dima, A. L., Easthall, C., Taylor, N. J., & Li, Z. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s427207 · Cited by 10
“24 In contrast, less attention has been given both in the literature and healthcare practice to the negative emotions evoked by the prospect of medicine taking which was also frequently reported on the IMAB-Q.”
BackgroundExperiences of Facilitators and Inhibitors to Treatment Adherence in Patients with Heart Failure
Gheiasi, S. F., Cheraghi, M. A., Dastjerdi, M., Navid, H., Khoshavi, M., Peyrovi, H., Khachian, A., Seylani, K., Esmaeili, M., & Navab, E. (2023) · Clinical Nursing Research · doi:10.1177/10547738221147402 · Cited by 18
“…reported that economic problems and lack of support from family or others are among the cultural, social, and economic barriers to medical adherence of people with chronic conditions such as cardiovascular disease (Kvarnström et al., 2021), which are consistent with the result of the present study.”
BackgroundResultInfluentialSami, R., Salehi, K., Hashemi, M., Haghighat, S., & Atashi, V. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073972 · Cited by 9
Graabæk, T., Rasmussen, A. J., Mai, A., Rossing, C., & Hedegaard, U. (2022) · Pharmacy Education · doi:10.46542/pe.2022.221.744760 · Cited by 4
“Poor communication between healthcare professionals and patients and/or relatives is abundant (Vermeir et al., 2015; Akinyelure et al., 2022) and can lead to decreased medication adherence (Kvarnström et al., 2021) and adverse health outcomes (Giardina et al., 2020; Humphries et al., 2020).”
BackgroundSkeens, M. A., Kochashvili, M., Benhayoun, A., Ralph, J. E., Bajwa, R. P. S., Vannatta, K. A., Gerhardt, C. A., & Sezgın, E. (2024) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2024.10.009 · Cited by 8
Khaiser, U. F., Sultana, R., Das, R., Alzahrani, S. G., Saquib, S. A., Shamsuddin, S. V., & Fareed, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302546 · Cited by 14
Jovičić, S. M. (2024) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320241250293 · Cited by 10
“19 Moreover, Informational technologies encounter dif fi cul-ties de fi ning ownership, the appliance of language, and implementing a new system into the old since systems are usually limited to one speci fi c disease.”
Richards, K., Mantri, S., Brown, C. M., Johnsrud, M. T., Arcona, S., & Sasané, R. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s473991 · Cited by 8
“10,11 It is important to collect patient experience data related to medications to gain more comprehensive insight into chronic diseases as experienced in the real world.”
BackgroundItalian Translation and Validation of the Original ABC Taxonomy for Medication Adherence
Mucherino, S., Maffoni, M., Cena, C., Armando, L. G., Guastavigna, M., Orlando, V., Orofino, G., Traina, S., Giardini, A., Menditto, E., et al. (2023) · Healthcare · doi:10.3390/healthcare11060846 · Cited by 11
“In this way, more “expert” patients could gain self-efficacy, which represents an essential skill to effectively manage their condition, organizing and implementing a set of actions needed to cope effectively with complex therapeutic regimens and, through the activation of cognitive, emotional, relational, and behavio…”
Backgroundİlhan, N., Savcı, C., & Yildirim, S. (2025) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.14303 · Cited by 11
Sundriyal, D., Kapoor, M., Antil, P., Gupta, S., Kumar, P., Shriwastav, U. K., & Sehrawat, A. (2024) · JCO Global Oncology · doi:10.1200/go-24-00411 · Cited by 7
Barriers to Treatment Adherence Among Older Adults With Type 2 Diabetes: A Qualitative Study
Maghsoudi, Z., Sadeghi, A., Oshvandi, K., Ebadi, A., & Tapak, L. (2023) · Journal of Gerontological Nursing · doi:10.3928/00989134-20221206-04 · Cited by 9
Metadata
- Authors
- Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Kvarnström, Kirsi
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2021-07-20
- Volume
- 13
- Issue
- 7
- Pages
- 1100
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC8309154
- OpenAlex
- W3184262661
- Cited by
- 470
- References
- 87
- Citations by year
- 2026: 99 · 2025: 144 · 2024: 113 · 2023: 82 · 2022: 29 · 2021: 3
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- The Foundation for Municipal Development, Finland (3.6.2019)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- medication adherence, chronic disease, patient factors, barriers to adherence, facilitators of adherence, patient-provider communication, trust in healthcare providers, social support, sociocultural factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.